Release Date: 22/11/10 09:25 Summary: Chairman's and CEO's Address to Shareholders Price Sensitive: Yes Download Document 4.26MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling